A previous study has shown the therapeutic action of ghrelin in both chemical (2,4,6-trinitrobenzene sulfonic acid, TNBS) and DSS-induced colitis, experimental models of Crohn’s disease and ulcerative colitis, respectively [22]. This evidence concerns the gene GHRL and Crohn disease.